What does Prime Medicine, Inc. (PRME) do?

Prime Medicine, Inc. (PRME) is a publicly traded company in the Healthcare sector.

What sector does PRME operate in?

Prime Medicine, Inc. operates in the Healthcare, specifically within the Biological Products, (No Diagnostic Substances) industry. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find PRME earnings analysis?

AlphaOS publishes an earnings intelligence page for Prime Medicine, Inc. (PRME) covering results, guidance context, and AI-assisted analysis. See /stocks/PRME/earnings. Content is for research and education — not investment advice.

Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

PRME

Prime Medicine, Inc.

Healthcare · Biological Products, (No Diagnostic Substances)

$2.90Sep 25, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

Prime Medicine, Inc. shows decelerating business momentum based on AlphaOS pipeline evidence.

TrajectoryDecelerating

3 signals not yet derived from pipeline evidence

Pipeline evidence · 2d ago

PRME's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on PRME.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q4 2025

Full PRME earnings analysis

Reported figures for Prime Medicine, Inc. — research only, not investment advice.

Revenue YoY: -100.0%

Latest Intelligence

Updated September 27, 2026

What happened recently for Prime Medicine, Inc. (PRME) — events, not interpretation.

Event: Reported Q4 2025 revenue -100% YoY.
Also: Last session September 25, 2026 at $2.9.
Source: Q4 2025 earnings

Research & analysis only — not investment advice.

Building company intelligence…

Prime Medicine, Inc. (PRME)

Healthcare · Biological Products, (No Diagnostic Substances)

Investment Snapshot above is the primary AlphaOS analysis for Prime Medicine, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:: Healthcare
Industry:: Biological Products, (No Diagnostic Substances)
Market cap:: $525.99M
Revenue:: $1.23M

PRME earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Prime Medicine, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.